News|Articles|January 28, 2026
Enhanced Paveway™ PLUS Selects Expression Organisms Based on Titer Plus Quality
Author(s)FUJIFILM Biotechnologies
Discover the future of microbial expression with a platform that optimizes strain selection, expression systems, and purification methods, providing actionable insights in just eleven weeks.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
How Digitalization Is Transforming Pharmaceutical Manufacturing Processes
3
How a Government Shutdown Causes FDA Inspection Bottlenecks and Backlogs
4
GSK’s RSV Vaccine Approved in Europe
5